SPARC Drives Tubulointerstitial Fibrosis through Regulating the CBP-DOT1L Pathway
Huimin Jiang, Qing Yang, Kuo Wang, Qinqin Tan, Chenyang Xiong, Xindi Zhou, Chun Gan, Han Xiao, Lan Qiu, Yaxi Chen, Mo Wang, Haiping Yang, Wei Jiang, Qiu Li · 2026
Read SPARC Drives Tubulointerstitial Fibrosis through Regulating the CBP-DOT1L Pathway by Huimin Jiang, Qing Yang, Kuo Wang, Qinqin Tan, Chenyang Xiong, Xindi Zhou, Chun Gan, Han Xiao, Lan Qiu, Yaxi Chen, Mo Wang, Haiping Yang, Wei Jiang, Qiu Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13215461.txt.
Description
Huimin Jiang and thirteen co-authors identify the protein SPARC as a driver of kidney scarring through an epigenetic relay, in a two thousand twenty-six nephrology paper. Tubulointerstitial fibrosis is the common final pathway as chronic kidney disease advances to failure.
SPARC levels tracked fibrosis severity in human biopsies and two mouse injury models, and deleting the gene markedly reduced scarring. Mechanistically, SPARC stabilizes the enzyme DOT1L, boosting a histone mark that switches on fibrotic programs in tubule cells. The acetyltransferase CBP controls DOT1L's stability through MEK-ERK signaling. Blocking any link in the SPARC-CBP-DOT1L chain, the authors argue, could slow fibrotic progression where few treatments exist.
Catalog record
| CREATOR | Huimin Jiang, Qing Yang, Kuo Wang, Qinqin Tan, Chenyang Xiong, Xindi Zhou, Chun Gan, Han Xiao, Lan Qiu, Yaxi Chen, Mo Wang, Haiping Yang, Wei Jiang, Qiu Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |